![Kimberly Murphy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kimberly Murphy
Directeur/Membre du Conseil chez
Blue Water Acquisition Corp. II
Profil
Kimberly M.
Murphy is currently an Independent Director at Blue Water Acquisition Corp.
II.
Former roles include Chairman at Clarus Therapeutics, Inc. and Clarus Therapeutics Holdings, Inc. from 2020 to 2022; Director-HPV & Gardasil Franchise at Merck & Co., Inc. from 1999 to 2005; Director at Biotechnology Innovation Organization; Independent Non-Executive Director at Blue Water Biotech, Inc. from 2020 to 2023; Independent Director at Blue Water Acquisition Corp.; Director at Oragenics, Inc. from 2024 to 2024; Vice President at Novartis AG from 2014 to 2015; Vice President-Influenza Franchise at GSK Plc from 2016 to 2019; and Head-Meningococcal Franchise at Novartis Vaccines & Diagnostics, Inc. in 2010.
Education includes undergraduate studies at Old Dominion University and an MBA from St. Joseph's University.
Postes actifs de Kimberly Murphy
| Sociétés | Poste | Début |
|---|---|---|
Blue Water Acquisition Corp. II
 Blue Water Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Anciens postes connus de Kimberly Murphy
| Sociétés | Poste | Fin |
|---|---|---|
| ORAGENICS, INC. | Directeur Général | 12/02/2024 |
Blue Water Biotech, Inc.
 Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops universal flu vaccine | Directeur/Membre du Conseil | 13/01/2023 |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Président | 31/10/2022 |
| GSK PLC | Corporate Officer/Principal | 01/01/2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01/05/2015 |
Formation de Kimberly Murphy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Oragenics, Inc.
 Oragenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics and treatments against infectious disease and oral mucositis | Health Technology |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Old Dominion University
 Old Dominion University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops universal flu vaccine | Health Technology |
Blue Water Acquisition Corp.
 Blue Water Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Clarus Therapeutics Holdings, Inc.
 Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
Blue Water Acquisition Corp. II
Blue Water Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
